MİRİOĞLU, Ş. Et Al. 2023. Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?. Turkish journal of nephrology (Online) , vol.32, no.3 , 209-215.

MİRİOĞLU, Ş., Akyildiz, A., uçar, a. r., ULUDAĞ, Ö., ÖZLÜK, Y., DİRİM, A. B., ... DEMİR, E.(2023). Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?. Turkish journal of nephrology (Online) , vol.32, no.3, 209-215.

MİRİOĞLU, Şafak Et Al. "Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?," Turkish journal of nephrology (Online) , vol.32, no.3, 209-215, 2023

MİRİOĞLU, Şafak Et Al. "Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?." Turkish journal of nephrology (Online) , vol.32, no.3, pp.209-215, 2023

MİRİOĞLU, Ş. Et Al. (2023) . "Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?." Turkish journal of nephrology (Online) , vol.32, no.3, pp.209-215.

@article{article, author={Şafak MİRİOĞLU Et Al. }, title={Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?}, journal={Turkish journal of nephrology (Online)}, year=2023, pages={209-215} }